michelcarroll/llama2-earnings-stock-prediction-fine-tune huggingface dataset:
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. Well, let me just kind of talk about our outlook there, and I'll have Ron talk about our investment strategy tied to that because, obviously, we see this liquidity, I think the team has done a very good job taking advantage of it and getting some nice interest -- net interest income growth on it. But I think we -- so we had an incredible quarter of growth on deposits.
We think that's probably going to tail off a bit because the stimulus payments that fueled a fair amount of that are -- look to be at their end. We're seeing the PPP forgiveness come in which is building it. Yet, as the economy gets stronger and people have more places to spend money and feel more comfortable taking trips and doing other things, we expect to see some of that flow out a bit.
In terms of -- but overall, I'd say it's -- we feel it's very sticky, most of that. That's why I stress the core relationships or the core deposits are -- in our core -- what we would call core deposits. So we feel like they're in a relationship account. So any -- if there is a slow -- slower growth rate there, I think we'll see that over time. And Ron, do you want to comment on the -- our investment strategy with those excess deposits?

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Well, there's discussion -- good morning, Tanya, first. So, there's discussion in the countries as you've probably seen in Chile. In Argentina, it seems that actually it might go the other way for us. So, that can be good in the future or for the future project we have in the country. In Brazil, it's pretty quiet now too with COVID. All our operation, I'm happy, I'm touching wood here, they have not been really impacted by COVID. But we don't really hear anything. I don't know, Jason, if you want to have something. But so far, we heard that Chile might do something, maybe that will impact more the copper, the big copper business than the gold business. But so far, there's no changes up to now.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Are we all set there, Gokul?

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Well, if quality is always at the top of the list execution, the complexity of operating sort of a complex customers such as Centene, I mean, that's pretty critical as well.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Well, thanks Adam for the question. And let me just start with saying, we are very pleased with the 2021 seed selling season. You are correct that the Canadian crop has really been dry in that area and we might see some really strong follow-through the next season from them. But we continue to build momentum in seed, and we do expect it likely to grow the between half and full share point on seed across the four major crops, and that share growth and acreage increase, we didn't see a lot of shifting between crops or brands. But David, do you want to fill in some of that -- in your area?

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah. I mean, the short answer, Jeff, it is -- you're pretty much right on your numbers. It's an outcome of strong returns on pension assets last year. So that number is really known coming into the year. And what we see right now, we expect the number for next year to be similar, that I can change depending on what happens in the market between now and the end of the year. But right now, we assume it will be similar to this year.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes, sure, Vedula, thank you for the question. And I agree with you. We're very pleased with the way that the securitization path has gone because we believe it's good for all of the stakeholders that we deal with. Let me do this just to round out the context around your question. I'll ask Caron to speak to the mechanics of the way that securitization will work. And then, Curtis can pick up and talk a little bit about both the impact -- the way that it works from a regulatory standpoint and the impact on our forward capex planning. Caron?

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes, thank you. Congrats on the strong results and outlook. I had two as well. You're returning cash well above 100% of free cash flow and you just raised your dividend as well. I know you spoke about very strong capital return program at your -- at your Analyst Day earlier. Just wondering as you're thinking about the outlook here, anything that has changed in the market that from a pricing or demand standpoint that is sort of bolstering the confidence?
And secondly, last night Intel spoke about China's cloud slowdown given regulatory pressures over there. Are you seeing any of that? And is that contemplated in your raised fiscal year guide? Thank you.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Hi. Good afternoon, everyone. Thanks so much for taking the question. Just -- and congrats on a good quarter. Just a follow-up to Josh's question on the backlog. I guess, Mike, I am just curious, previously, you talked about this knocking a backlog type of market given the high mortality rate for these patients if they don't get treated. So, I guess, I am curious about the increased level of confidence that there is a backlog, first of all. And second of all, is it really about low risk patients and if you have a sense of whether you are treating a higher percentage of low risk patients right now. Any color you can give on the patient mix that gives you conviction that this is a backlog work down versus just strong underlying volume?

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
I think for this year, the likely allocation will be around 65% for assembly, roughly 23% to 25% for tests, a little bit for material and then roughly 9% to 10% for EMS.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes, we are generating revenue. Actually, we already generated revenue, over 1 million. Or, actually, I will not say revenue, revenue cause that's a recognition, right, accounting-basis measurement. Actually, the contract value, over 1 million, we already signed such contracts for the VaaS customers.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes, it's a good question. And I think if you look back to how we operated in 2019 pre-pandemic, the two divisions that got most of the new capital were the Modular division and the TRS division. And within modulars, not only do we have opportunities to grow in the commercial and education markets for modular buildings, but also with our Portable Storage business, we continue to expand the geographic footprint there. So I think those things are still opportunities for us. And as Joe mentioned earlier, our teams have done a lot of work looking at their businesses, looking at where they want to play, where they see growth opportunities in this year and beyond. And so all those plans will get executed, and the pacing will reflect, again, some of the pacing of demand recovery after the pandemic.
And as you know, with TRS-RenTelco, there's still a long tail to opportunities tied to 5G. We've seen more of that in R&D work. We'll continue to support that with equipment purchases. If you look at some of our operating metrics, the team at TRS have done really a very nice job managing the equipment pool and by the standards of that business, finished the year with very high utilization. So when they're in that kind of a position, if they see more incremental growth, it will make sense to add to the fleet.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
No, I think there's still meaningful opportunity there. But like I said, Matt, I don't -- we're at roughly what about $540 per case today out of a, let's say, potential of about $1,000 per case. And we might see that continue to improve. I expect that it will, but I don't expect it to occur or to improve at the same rate that we've seen up until now. We will get to a point where we've kind of gotten the access to the cases that we're going to get. And so we're not going to get to $1,000 per case. We will see continuous improvement over time but we're going to see that begin to kind of level out and flatten out and eventually what will kind of be balanced at some number in terms of our penetration of these cases.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Humphrey, it's Dennis, let me take that. Thank you for the question. I would say it this way. It's just X month's execution on a very strong model and when I talk about strong model I talked about, we have a good product portfolio, I mentioned a couple of the strong products within the portfolio. I've mentioned that we focus on the fastest growing markets and we have a top 10 position in each one of those markets were leveraging some of the strength of the overall organization to add distribution strength LSD in particular. We also have good reach in our consultancy channels. So just overall, it's just execution on a model, which we think has demonstrated good growth and good sales over several years in a row now.
Turning to total deposits, we are seeing strength and recurring deposits, and that's related to more participants and employers increasing their contributions to their employees plans; so, I would just say there's nothing unusual about the quarter. That's just great execution on a good model that's been in place for some time.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Steve, do you want to start with just on-boarding and what you see in the future and I think there is a tremendous overlap with Art's and maybe you can share his thoughts as well.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Okay. On the supply chain question and any impact that that may be having on the Lilly Pulitzer after party sale later in the year, the way that I would answer that, Tracy, is the primary driver or the root cause, if you will, of not having as much inventory is the higher sell-through that we've had year-to-date. However, the supply chain issues make it harder for us to chase inventory really for full-price business as well as -- as for that would ultimately end up, leaving us possibly with more inventory for the after party sales.
So the -- we are having some challenges with delays in shipping as well as some delays in production at the factory and due to the COVID pandemic. As much as possible, we've obviously tried to factor all of that into our forecast and think we've sort of captured that. But the real cause is the higher-than-anticipated full-price selling during the early part of the year.
And then on the outlet stores?

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah, Jeff, it starts with really confidence in earnings and the ability to turn it into cash. And so it's really the commitment we've had for a long time about deploying cash to shareholders over time. And so the confidence there on the $0.5 billion is really that.
Further, there is a strong pipeline. We are very, very disciplined about how we look at acquisitions. We still feel the intrinsic value of our own share price offers opportunities. So I'm confident that one way or the other, we'll split it. But as -- yeah, we'll be able to spend it. But as I said on the last call, the pipeline is robust, and I'm sure that that we'll find some value before the end of the year there.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Hey, guys. Thanks so much for taking my questions here. Two for me. Maybe, one, to follow-up on the biomarker collaborations.
I'm just wondering if you could elaborate a bit more. I would presume that patients that are identified via Caris would need to be referred to active participating clinical sites. I'm just wondering how efficient that process is. And does the collaboration function of local assessment that would then need to be centrally confirmed? Thanks.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Good morning. I wanted to talk about the outlook for renewable and energy storage costs, but take it from a different perspective. I know there's been a lot of attention on commodity cost dynamics. But on the more positive side, I was interested in your views on sort of innovations that could result in cost reduction breakthroughs.
And there's interesting article this week in the Wall Street Journal in storage, and we're trying to make sure we're thinking through potential areas of innovation. I was just curious at a high level, -- Are there areas of innovation, whether it be in storage or in solar, green hedging, just things that excite you in terms of the potential to have very significant impacts on cost or performance.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Great, thanks for taking the question. Gene, I was wondering, it's great to see the recovery with Olive Garden, but as their percentage increase versus '19, it is less than some of the other publicly traded companies that have reported. Can you just maybe give us a couple of the reasons why you think that is? I imagine because you're at high capacity in '19 or are you have less marketing, but maybe just help us understand why Olive Garden has recovered I think to a less degree than a lot of the others?

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah. What I can tell you is that we -- when we share a spreadsheet model with payers and have them put their own numbers into the model, one of the things that -- in the publication that was quite evident is no matter what numbers you put in, there is a way to save money. And because of that's termed a dominant strategy, and that's the way the authors characterized the strategy. When we show this to payers, the savings are enormous.
If anything, the publication was conservative in its views and we hear some payers telling us we believe these savings are even higher. They're quite impressed with the amount -- with the savings that are [audio gap] Remember, the great majority of preterm deliveries cannot be detected by today's current clinical practice. About one in six are -- those are pregnancies of -- in women carrying a single fetus where the pregnancy is at risk and who will deliver prematurely. Only about one in six are identified by current methods.
Using our test with current methods, it increases the detection by fourfold. That's a significant increase. And being able to intervene early, as the Anthem data show and as our perspective intervention trial -- the present PTB trials show there is benefit in finding those pregnancy and being more proactive in individualized care you can give to those pregnancies who truly are at risk.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
So the short answer is yes, we do have customer traction, and we do expect a very modest contribution in our fiscal 2022. The big growth will come in 2023. So I think we're doing all the right things. We are known in the metro and long-haul area, as you've highlighted, to have best-in-class products. And so we're very busy right now focusing on supporting a wide range of module manufacturers that want to get into this business. It's going to break away from being a captured market to more of a merchant market for module solutions here. And we think we will have a very strong position in the next one to two years.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. We're a work from the office team and we did move 90% of our employees home when the virus first hit back in, I guess, it was March or April of 2020. But by October, we're basically back in the office and given the number of new hires, the training component. We want those new employees to learn our culture. Working together in an office facilitates communication. A big part of our business strategy is delivering best-in-class service to our brokers. And all that -- all those goals are furthered by having everybody work together in an office. And so, that's how we're operating.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
It's a great question, and we're going to talk about precisely this topic on May 20. What we're going to unveil at that Investor Day is our strategy to increase retention, increase the stickiness of existing customers that we win and also how we will prospect new customers on an ongoing rate at the level that we currently are. It's an end comment on the independent local customer level, for sure. It always has been, it always will be.
But the tools that we're bringing to the industry related to being right on price, having a promotional offer that's relevant and specific to that individual because we know more about them than anyone else because of the amount of data that we have and to provide a merchandising and marketing strategy that meets the needs of those each individual customers, we can do better on all of those things as a company. And we are doing better. And I respectfully and humbly submit, we'll be the best in the industry at doing that. And we look forward to talking to you more about it on the 20th.

    Prediction (one of UP, DOWN, SAME): SAME